Dr. Botros Rizk, MD

NPI: 1851346183
Total Payments
$499,499
2023 Payments
$695.81
Companies
10
Transactions
526

Payment Breakdown by Category

Other$402,640 (80.6%)
Travel$69,961 (14.0%)
Consulting$14,850 (3.0%)
Food & Beverage$11,933 (2.4%)
Research$68.77 (0.0%)
Education$45.89 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $395,140 112 79.1%
Travel and Lodging $69,961 214 14.0%
Consulting Fee $14,850 3 3.0%
Food and Beverage $11,933 190 2.4%
Honoraria $7,500 2 1.5%
Unspecified $68.77 1 0.0%
Education $45.89 4 0.0%

Payments by Type

General
$499,430
525 transactions
Research
$68.77
1 transactions

Top Paying Companies

Company Total Records Latest Year
AbbVie Inc. $468,778 475 $0 (2023)
Hologic, LLC $20,374 36 $0 (2022)
Boston Scientific Corporation $7,673 5 $0 (2018)
Myovant Sciences Inc. $2,219 3 $0 (2022)
Vitrolife Inc. $187.54 1 $0 (2023)
Lumenis, Inc $113.34 1 $0 (2018)
Sumitomo Pharma America, Inc. $99.24 1 $0 (2023)
Bayer HealthCare Pharmaceuticals Inc. $26.56 2 $0 (2018)
Hologic Sales and Service, LLC $14.43 1 $0 (2023)
Ferring Pharmaceuticals Inc. $14.40 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2023 $695.81 4 AbbVie Inc. ($394.60)
2022 $16,136 17 ABBVIE INC. ($14,820)
2021 $75,660 81 AbbVie Inc. ($74,555)
2020 $62,494 55 AbbVie Inc. ($62,364)
2019 $156,514 163 AbbVie, Inc. ($147,504)
2018 $103,974 109 AbbVie, Inc. ($91,214)
2017 $84,025 97 AbbVie, Inc. ($77,926)

All Payment Transactions

526 individual payment records from CMS Open Payments — Page 1 of 22

Date Company Product Nature Form Amount Type
12/13/2023 Hologic Sales and Service, LLC MYOSURE TISSUE REMOVAL DEVICE (Device) Food and Beverage In-kind items and services $14.43 General
Category: Surgical
07/31/2023 Vitrolife Inc. Food and Beverage Cash or cash equivalent $187.54 General
06/08/2023 Sumitomo Pharma America, Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $99.24 General
Category: HORMONE THERAPY
01/05/2023 AbbVie Inc. ORIAHNN (Drug), ORILISSA Travel and Lodging In-kind items and services $394.60 General
Category: WOMENS HEALTH
12/20/2022 ABBVIE INC. ORIAHNN (Drug), ORILISSA Food and Beverage In-kind items and services $12.36 General
Category: WOMENS HEALTH
11/29/2022 Hologic, LLC ACESSA PROVU SYSTEM (Device) Food and Beverage In-kind items and services $167.23 General
Category: Surgical
10/25/2022 Myovant Sciences Inc. MYFEMBREE (Drug) Food and Beverage In-kind items and services $78.76 General
Category: HORMONE THERAPY
07/28/2022 ABBVIE INC. ORILISSA (Drug) Travel and Lodging In-kind items and services $35.10 General
Category: WOMENS HEALTH
07/25/2022 ABBVIE INC. ORIAHNN (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,200.00 General
Category: WOMENS HEALTH
07/25/2022 ABBVIE INC. ORIAHNN (Drug), ORILISSA Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: WOMENS HEALTH
07/20/2022 ABBVIE INC. ORIAHNN (Drug), ORILISSA Travel and Lodging In-kind items and services $737.20 General
Category: WOMENS HEALTH
07/20/2022 ABBVIE INC. ORIAHNN (Drug), ORILISSA Travel and Lodging In-kind items and services $271.27 General
Category: WOMENS HEALTH
07/20/2022 ABBVIE INC. ORIAHNN (Drug), ORILISSA Food and Beverage In-kind items and services $123.84 General
Category: WOMENS HEALTH
07/20/2022 ABBVIE INC. ORIAHNN (Drug) Food and Beverage In-kind items and services $26.26 General
Category: WOMENS HEALTH
07/19/2022 ABBVIE INC. ORIAHNN (Drug) Travel and Lodging In-kind items and services $271.27 General
Category: WOMENS HEALTH
05/31/2022 ABBVIE INC. ORILISSA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: WOMENS HEALTH
05/23/2022 ABBVIE INC. ORILISSA (Drug) Food and Beverage In-kind items and services $22.88 General
Category: WOMENS HEALTH
04/07/2022 ABBVIE INC. ORILISSA (Drug) Travel and Lodging In-kind items and services $23.40 General
Category: WOMENS HEALTH
02/23/2022 Myovant Sciences Inc. MYFEMBREE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,070.00 General
Category: HORMONE THERAPY
02/16/2022 ABBVIE INC. ORILISSA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,000.00 General
Category: WOMENS HEALTH
02/09/2022 ABBVIE INC. ORILISSA (Drug) Food and Beverage In-kind items and services $96.19 General
Category: WOMENS HEALTH
10/28/2021 Myovant Sciences Inc. MYFEMBREE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,070.00 General
Category: HORMONE THERAPY
07/27/2021 AbbVie Inc. ORILISSA (Drug), ORIAHNN Travel and Lodging In-kind items and services $352.80 General
Category: WOMENS HEALTH
07/27/2021 AbbVie Inc. ORILISSA (Drug), ORIAHNN Travel and Lodging In-kind items and services $170.66 General
Category: WOMENS HEALTH
07/27/2021 AbbVie Inc. ORILISSA (Drug), ORIAHNN Travel and Lodging In-kind items and services $158.09 General
Category: WOMENS HEALTH

About Dr. Botros Rizk, MD

Dr. Botros Rizk, MD is a Reproductive Endocrinology healthcare provider based in Mobile, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851346183.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Botros Rizk, MD has received a total of $499,499 in payments from pharmaceutical and medical device companies, with $695.81 received in 2023. These payments were reported across 526 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($395,140).

Practice Information

  • Specialty Reproductive Endocrinology
  • Location Mobile, AL
  • Active Since 05/24/2006
  • Last Updated 02/17/2017
  • Taxonomy Code 207VE0102X
  • Entity Type Individual
  • NPI Number 1851346183

Products in Payments

  • Lupron (Drug) $163,902
  • Orilissa (Drug) $149,424
  • ORIAHNN (Drug) $97,402
  • ORILISSA (Drug) $54,732
  • MyoSure (Device) $14,094
  • SYMPHION (Device) $6,731
  • Myosure (Device) $5,265
  • MYFEMBREE (Drug) $2,318
  • THERAPIES (Device) $942.04
  • Fluent (Device) $350.92
  • ACESSA PROVU SYSTEM (Device) $183.23
  • MyoSure and Aquilex (Device) $127.90
  • Myosure Manual (Device) $125.60
  • ThinPrep (Device) $110.77
  • MyoSure Aquilex Reach (Device) $97.29
  • MYOSURE TISSUE REMOVAL DEVICE (Device) $33.62
  • Kyleena (Drug) $26.56
  • MENOPUR (Drug) $14.40

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Reproductive Endocrinology Doctors in Mobile